Showing 1,881 - 1,900 results of 3,614 for search '(( significant decrease decrease ) OR ( significant risk decrease ))~', query time: 0.51s Refine Results
  1. 1881

    Data Sheet 1_Trends in nontraumatic subarachnoid hemorrhage-related mortality among young adult (15–64 years) population in the United States, 1999–2022.docx by Olivia Foley (20535083)

    Published 2025
    “…Background<p>Nontraumatic subarachnoid hemorrhages (NSAH) are the result of intracranial aneurysm rupture and involve bleeding into subarachnoid space. NSAH causes significant stroke burden among adults in the United States (US). …”
  2. 1882

    Table 1_Association between oxidative balance score and all-cause and cancer-specific mortality among cancer survivors.pdf by Qingmei Gao (20905781)

    Published 2025
    “…In the fully adjusted model, multivariable Cox regression revealed that each unit increase in OBS was linked to a 1.8% decrease in all-cause mortality risk (HR 0.982, 95%CI 0.972-0.991) and a 2.6% decrease in cancer-specific mortality risk (HR 0.974, 95%CI 0.958-0.991). …”
  3. 1883

    Data Sheet 1_Analysis and comparison of the trends in burden of spinal cord injury in China and worldwide from 1990 to 2021: an analysis of the global burden of disease study 2021.... by Hao Qin (113159)

    Published 2025
    “…Age-period-cohort analysis showed that the risk of SCI incidence increased with age in China, though both period and cohort effects demonstrated a significant downward trend. …”
  4. 1884

    Data Sheet 2_Analysis and comparison of the trends in burden of spinal cord injury in China and worldwide from 1990 to 2021: an analysis of the global burden of disease study 2021.... by Hao Qin (113159)

    Published 2025
    “…Age-period-cohort analysis showed that the risk of SCI incidence increased with age in China, though both period and cohort effects demonstrated a significant downward trend. …”
  5. 1885

    Datasheet1_Causal relationship between immunophenotypes and mitral valve prolapse: a bidirectional Mendelian randomization study.pdf by Yue Wang (65477)

    Published 2024
    “…</p>Results<p>The findings indicated that multiple immune cell phenotypes potentially cause changes in the risk of developing MVP. After adjusting for the false discovery rate, nine immune phenotypes were found to increase the risk of MVP, while nine others appeared to decrease it. …”
  6. 1886

    Table1_Causal relationship between immunophenotypes and mitral valve prolapse: a bidirectional Mendelian randomization study.xlsx by Yue Wang (65477)

    Published 2024
    “…</p>Results<p>The findings indicated that multiple immune cell phenotypes potentially cause changes in the risk of developing MVP. After adjusting for the false discovery rate, nine immune phenotypes were found to increase the risk of MVP, while nine others appeared to decrease it. …”
  7. 1887

    Image 1_Alpha oscillatory dysregulation: mapping EEG oscillatory in suicidal depression.tiff by Yue Zhao (186573)

    Published 2025
    “…</p>Results<p>EEG analysis showed a significant increase in alpha-band PSD and a significant decrease in FAA in DSI compared to DNSI (p < 0.05). …”
  8. 1888

    Table 1_Alpha oscillatory dysregulation: mapping EEG oscillatory in suicidal depression.docx by Yue Zhao (186573)

    Published 2025
    “…</p>Results<p>EEG analysis showed a significant increase in alpha-band PSD and a significant decrease in FAA in DSI compared to DNSI (p < 0.05). …”
  9. 1889

    Image1_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…The use of SGLT2i was associated with a 65% decrease in the risk of kidney composite endpoint events (hazard ratio 0.35, 95% CI 0.19–0.63).…”
  10. 1890

    Image2_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…The use of SGLT2i was associated with a 65% decrease in the risk of kidney composite endpoint events (hazard ratio 0.35, 95% CI 0.19–0.63).…”
  11. 1891

    Image8_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…The use of SGLT2i was associated with a 65% decrease in the risk of kidney composite endpoint events (hazard ratio 0.35, 95% CI 0.19–0.63).…”
  12. 1892

    Image5_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…The use of SGLT2i was associated with a 65% decrease in the risk of kidney composite endpoint events (hazard ratio 0.35, 95% CI 0.19–0.63).…”
  13. 1893

    Image6_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…The use of SGLT2i was associated with a 65% decrease in the risk of kidney composite endpoint events (hazard ratio 0.35, 95% CI 0.19–0.63).…”
  14. 1894

    Image3_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…The use of SGLT2i was associated with a 65% decrease in the risk of kidney composite endpoint events (hazard ratio 0.35, 95% CI 0.19–0.63).…”
  15. 1895

    DataSheet1_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.pdf by Xiang Xiao (44417)

    Published 2024
    “…The use of SGLT2i was associated with a 65% decrease in the risk of kidney composite endpoint events (hazard ratio 0.35, 95% CI 0.19–0.63).…”
  16. 1896

    Image4_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…The use of SGLT2i was associated with a 65% decrease in the risk of kidney composite endpoint events (hazard ratio 0.35, 95% CI 0.19–0.63).…”
  17. 1897

    Image7_Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China.TIF by Xiang Xiao (44417)

    Published 2024
    “…The use of SGLT2i was associated with a 65% decrease in the risk of kidney composite endpoint events (hazard ratio 0.35, 95% CI 0.19–0.63).…”
  18. 1898
  19. 1899
  20. 1900

    Table 1_Associations between ultra-processed foods intake and preserved ratio impaired spirometry in U.S. adults.docx by Weiliang Kong (12573067)

    Published 2025
    “…However, the highest quartile of UPFs (%Kcal) intake was significantly linked to increased PRISm risk (OR 1.36, 95% CI: 0.99–1.86, P for trend = 0.043). …”